Return On Equity in % of Kairos Pharma, LTD. from 2024 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Kairos Pharma, LTD. quarterly/annual Return On Equity history and change rate from 2024 to Q3 2025.
  • Kairos Pharma, LTD. Return On Equity for the quarter ending 30 Sep 2025 was -79.2 %.
Return On Equity, Quarterly (%)
Return On Equity, Annual (%)

Kairos Pharma, LTD. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -79.2 01 Jul 2025 30 Sep 2025
Q2 2025 -88.7 01 Apr 2025 30 Jun 2025
Q1 2025 -113 01 Jan 2025 31 Mar 2025
Q4 2024 -341 01 Oct 2024 31 Dec 2024

Kairos Pharma, LTD. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -341 01 Jan 2024 31 Dec 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.